Skip to main content
SpringerLink
Log in

Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag

  • Case Based Review
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Eltrombopag is a new thrombomimetic medication approved for the treatment of immune thrombocytopenia. There are very few reports on the use of eltrombopag in patients with thrombocytopenia associated with sytemic lupus.We present a recent case of a patient with lupus with severe thrombocytopenia refractory to conventional therapy and full recovery with the use of eltrombopag. The present status of the literature with the use of this medication in patients with lupus is reviewed and discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bashal F (2013) Hematological disorders in patients with systemic lupus erythematosus. Open Rheumatol J 7:87–95

    Article  PubMed Central  PubMed  Google Scholar 

  2. Provan D, Stasi R, Newland AC et al (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115:168–186

    Article  CAS  PubMed  Google Scholar 

  3. Keeling DM, Isenberg DA (1993) Haematological manifestations of systemic lupus erythematosus. Blood Rev 7:199–207

    Article  CAS  PubMed  Google Scholar 

  4. Hallam S, Provan D, Newland AC (2013) Immune thrombocytopenia—what are the new treatment options? Expert Opin Biol Ther 13:1173–1185

    Article  CAS  PubMed  Google Scholar 

  5. Imbach P, Crowther M (2011) Thrombopoietin-receptor agonists for primary immune thrombocytopenia. N Engl J Med 365:734–741

    Article  CAS  PubMed  Google Scholar 

  6. Alkaabi JK, Alkindi S, Riyami NA et al (2012) Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus. Lupus 21:1571–1574

    Article  CAS  PubMed  Google Scholar 

  7. Cela I, Miller IJ, Katz RS et al (2010) Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE). Clin Adv Hematol Oncol 8:806–809

    PubMed  Google Scholar 

  8. Kuter DJ, Begley CG (2002) Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood 100:3457–3469

    Article  CAS  PubMed  Google Scholar 

  9. Olnes MJ, Scheinberg P, Calvo KR et al (2012) Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med 367:11–19

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Kremer J, Li ZG, Hall S et al (2013) Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial. Ann Intern Med 159:253–261

    PubMed  Google Scholar 

  11. Li J, Yang C, Xia Y et al (2001) Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 98:3241–3248

    Article  CAS  PubMed  Google Scholar 

  12. Cheng G, Saleh MN, Marcher C et al (2011) Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study. Lancet 377:393–402

    Article  CAS  PubMed  Google Scholar 

  13. Bussel JB, Cheng G, Saleh MN et al (2007) Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 357:2237–2247

    Article  CAS  PubMed  Google Scholar 

  14. Saleh MN, Bussel JB, Cheng G et al (2013) Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. Blood 121:537–545

    Article  CAS  PubMed  Google Scholar 

  15. Kuter DJ, Bussel JB, Newland A et al (2013) Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy. Br J Haematol 161:411–423

    Article  CAS  PubMed  Google Scholar 

  16. Kuter DJ, Rummel M, Boccia R et al (2010) Romiplostim or standard of care in patients with immune thrombocytopenia. N Engl J Med 363:1889–1899

    Article  CAS  PubMed  Google Scholar 

  17. Bussel JB, Kuter DJ, George JN et al (2006) AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 355:1672–1681

    Article  CAS  PubMed  Google Scholar 

  18. Fain O, Ebbo M, Khellaf M et al (2013) Prolonged remission after TPO-receptor agonist discontinuation in adults with chronic ITP. Results of a French Observational Study. Blood 122:327

    Google Scholar 

  19. Qin P, Qiu J, Shao L et al (2013) Sustained complete remission of corticosteroid-resistant immune thrombocytopenia with a short course of recombinant human thrombopoietin. Blood 122:4746

    Article  Google Scholar 

  20. Desmond R, Townsley DM, Dumitriu B, et al (2014) Eltrombopag restores tri-lineage hematopoiesis in refractory severe aplastic anemia which can be sustained on discontinuation of drug. Blood 123:1818

    Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Hematology Service, Oncology Center, Hospital São José, Beneficência Portuguesa, São Paulo, Brazil

    Phillip Scheinberg

  2. Rheumatology Section, Federal University of Mato Grosso, Cuiaba, Brazil

    Cristiane Carvalho Singulane & Luis Sergio Guedes Barbosa

  3. Rheumatologist Hospital Israelita Albert Einstein, São Paulo, Brazil

    Morton Scheinberg

Authors
  1. Phillip Scheinberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cristiane Carvalho Singulane
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luis Sergio Guedes Barbosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Morton Scheinberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Morton Scheinberg.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scheinberg, P., Singulane, C.C., Barbosa, L.S.G. et al. Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag. Clin Rheumatol 33, 1347–1349 (2014). https://doi.org/10.1007/s10067-014-2600-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-014-2600-8

Keywords

Search

Navigation